185 related articles for article (PubMed ID: 7706519)
1. Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.
Schmitt FC; Andrade L
J Clin Pathol; 1995 Jan; 48(1):53-6. PubMed ID: 7706519
[TBL] [Abstract][Full Text] [Related]
2. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.
Zagouri F; Sergentanis TN; Nonni A; Papadimitriou CA; Michalopoulos NV; Domeyer P; Theodoropoulos G; Lazaris A; Patsouris E; Zogafos E; Pazaiti A; Zografos GC
BMC Cancer; 2010 Jul; 10():353. PubMed ID: 20602789
[TBL] [Abstract][Full Text] [Related]
4. Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma.
Shousha S; Lyssiotis T
Histopathology; 1978 Nov; 2(6):433-47. PubMed ID: 365699
[TBL] [Abstract][Full Text] [Related]
5. Gains and losses of HLA class II (DR) and CD4 in atypical hyperplasia, carcinoma in situ and infiltrating ductal carcinoma of the breast.
Tamiolakisl D; Venizelos I; Lambropoulou M; Jivannakis T; Seliniotakis E; Tsikouras P; Limberis V; Tsalkidis A; Papadopoulos N
Acta Medica (Hradec Kralove); 2004; 47(4):257-62. PubMed ID: 15844251
[TBL] [Abstract][Full Text] [Related]
6. CEA and HMFG in hyperplastic and malignant lesions of the breast.
De Potter CR; Beghin C; Praet MM; Pauwels CF; Roels HJ
Pathol Res Pract; 1988 Jun; 183(3):271-6. PubMed ID: 2843840
[TBL] [Abstract][Full Text] [Related]
7. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
Wittekind C; von Kleist S; Sandritter W
Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
[TBL] [Abstract][Full Text] [Related]
10. The distribution of carcinoembryonic antigen in breast carcinoma. Diagnostic and prognostic implications.
Kuhajda FP; Offutt LE; Mendelsohn G
Cancer; 1983 Oct; 52(7):1257-64. PubMed ID: 6192897
[TBL] [Abstract][Full Text] [Related]
11. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) in 120 mammary carcinomas and its correlation with tumor type, grading, staging plasma-CEA, and biochemical receptor status.
Böcker W; Schweikhart G; Pollow K; Kreienberg R; Klaubert A; Schröder S; Mitze M; Bahnsen J; Stegner HE
Pathol Res Pract; 1985 Nov; 180(5):490-7. PubMed ID: 3001680
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations.
Hussein MR; Hassan HI
J Clin Pathol; 2006 Sep; 59(9):972-7. PubMed ID: 16935972
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor A and B isoforms in the human breast and its disorders.
Ariga N; Suzuki T; Moriya T; Kimura M; Inoue T; Ohuchi N; Sasano H
Jpn J Cancer Res; 2001 Mar; 92(3):302-8. PubMed ID: 11267940
[TBL] [Abstract][Full Text] [Related]
15. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.
Ingegnoli A; d'Aloia C; Frattaruolo A; Pallavera L; Martella E; Crisi G; Zompatori M
Breast J; 2010; 16(1):55-9. PubMed ID: 19825003
[TBL] [Abstract][Full Text] [Related]
16. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
17. Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis.
Schmitt FC; Figueiredo P; Lacerda M
Virchows Arch; 1995; 427(3):251-8. PubMed ID: 7496593
[TBL] [Abstract][Full Text] [Related]
18. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G
Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003
[TBL] [Abstract][Full Text] [Related]
20. A dilutional immunoperoxidase study of proliferative ductal lesions and carcinomata of the breast.
Wells S; Hasleton PS
Histopathology; 1981 Sep; 5(5):517-26. PubMed ID: 6269985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
